%0 Journal Article %T A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease %A Schreiber, Stefan %A Siegel, Corey A %A Friedenberg, Keith A %A Younes, Ziad H %A Seidler, Ursula %A Bhandari, Bal R %A Wang, Ke %A Wendt, Emily %A McKevitt, Matt %A Zhao, Sally %A Sundy, John S %A Lee, Scott D %A Loftus, Edward V %J Journal of Crohn's and Colitis %V 12 %N 9 %P 1014-1020 %@ 1873-9946 %D 2018-08-29 %I Elsevier Science %~ DeepDyve